DC4U Technologies

GlycoDC™ Platform modulating the immune system

General Information
Company Name
DC4U Technologies
Founded Year
2006
Location (Offices)
The Netherlands +1
Founders / Decision Makers
Number of Employees
2
Industries
Biotechnology, Life Sciences, Medical Devices
Funding Stage
Grant
Social Media

DC4U Technologies - Company Profile

DC4U Technologies is a biotechnology startup established in 2006 with a focus on immunological application of glycobiology. The company's GlycoDC™ Platform has the capability to modulate the immune system, making it applicable to antigen-based therapeutics and products. Headquartered in The Netherlands, DC4U Technologies secured a grant investment on 25 October 2022 from Eureka Network. With its innovative platform technology and expertise in immunology, this startup presents a promising investment opportunity in the biotechnology sector.

Taxonomy: Life Science, Immunological Application, Glycobiology, Platform Technology, Immune System Modulation, Antigen Therapeutics

Funding Rounds & Investors of DC4U Technologies (3)

View All
Funding Stage Amount No. Investors Investors Date
Grant €1.70M 1 25 Oct 2022
Grant €2.70M 1 Eurostars 01 Nov 2016
Grant €2.50M 1 Eurostars 01 Jan 2015

Latest News of DC4U Technologies

View All

No recent news or press coverage available for DC4U Technologies.

Similar Companies to DC4U Technologies

View All
Optinize.com - Similar company to DC4U Technologies
Optinize.com Proactive customer engagement platform
Wikitia, The Encyclopedia from Verified Editors - Similar company to DC4U Technologies
Wikitia, The Encyclopedia from Verified Editors Verified Encyclopedia from Verified Editors with no bias.
Finata.id - Similar company to DC4U Technologies
Finata.id Profit, Sustain & Growth.